Notably, SPMI-HIF2-1 efficiently killed HCT116 p53+/+ but not p53-/- cancer cells, through an atypical degradation of both MDM2 and MDMX and activation of a p53-dependent apoptotic pathway. This evidence concerns the gene MDM2 and cancer.